Our Knowledge
We Vinkem, are one among the pioneer Indian pharmaceutical company to see immense value in investing in Research & Development (R&D). Our early investments in R&D, beginning two decades ago, enable us to make technology our key differentiator and develop a basket of ‘difficult to make’ niche oncological products and a partner of choice to various customers across the world. Our core strength lies in our ability to excel in developing generics and technologically complex products through focused teams in formulations, process chemistry and analytical development. We have the capability to deliver premium quality products within established timelines, at competitive price and without compromising on the quality.

VINKEM’s R&D is authenticated by the Indian Government’s DISR (Department of Science and Industrial Research).Its Seed funding has been granted by SFAC in recognition of outstanding support to farmers. The research strategy and implementation are well supported by a strong intellectual team having expertise and experience in chemistry, analytical techniques, dosage forms and global patent law. Our primary focus is on extraction, isolation and semi synthesis of hi-tech natural products.


Vinkem has developed in-house technical know-how for very large number of oncology and high value low volume molecules viz. Cyclophosphamide, Ifosfamide, Topotecan, Irinotecan, Docetaxel, Paclitaxel, Oxaliplatin, Carboplatin, Cisplatin, Zoledronic acid, Gemcitabine, Pemetrexed,Reserpine, Colchicine, Thiocolchicine, Coleus forskholin, Solanesol, Co-enzyme Q10, Buprenorphine, Dibekacin,Bortezomib Bendamustine etc. It has in its kitty 26 oncology molecules out of which 65 injectables could be made. Vinkem also manufactures Cyclophosphamide & Ifosfamide API. Of this, Cyclsophosphomide is a leading molecule in cancer care and Vinkem is the only company in the world to have technology for lyophilized dose of Cyclophosphamide - the safest and most efficacious dosage form of the drug.

Vinkem welcome young budding scientist to join hands with our research scientists working at our R&D center equipped with cutting-edge enabling technologies for research. Our scientists have expertise in developing generics, difficult to make technology intensive products, Active Pharmaceutical Ingredients (APIs), etc